DK2403
Based on 1 Customer Validation
DK2403 (compound 25) is a MAP2K7 inhibitor (IC50= 0.01 μM). DK2403 can effectively inhibit MAP2K7 without significantly disrupting the larger kinase group and can be used to study childhood T-cell acute lymphoblastic leukemia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 98.24%
- CAS 番号: 2902651-64-1
- 分子式: C19H17ClN4O2
- 分子量:368.82
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
生物活性
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Jurkat | IC50 |
1.4 μM
Compound: 25
|
Cytotoxicity against human Jurkat cells assessed as cell growth inhibition measured after 18 hrs by Celltiter-Glo luminescence assay
Cytotoxicity against human Jurkat cells assessed as cell growth inhibition measured after 18 hrs by Celltiter-Glo luminescence assay
|
[PMID: 37197477] |
| Jurkat | IC50 |
1.6 μM
Compound: 25
|
Cytotoxicity against human Jurkat cells assessed as cell growth inhibition measured after 18 hrs followed by compound washout by Celltiter-Glo luminescence assay
Cytotoxicity against human Jurkat cells assessed as cell growth inhibition measured after 18 hrs followed by compound washout by Celltiter-Glo luminescence assay
|
[PMID: 37197477] |
| Jurkat | IC50 |
2 μM
Compound: 25
|
Cytotoxicity against human Jurkat cells assessed as cell growth inhibition measured after 48 hrs by Celltiter-Glo luminescence assay
Cytotoxicity against human Jurkat cells assessed as cell growth inhibition measured after 48 hrs by Celltiter-Glo luminescence assay
|
[PMID: 37197477] |
| KOPTK1 | IC50 |
1.9 μM
Compound: 25
|
Cytotoxicity against human KOPT-K1 cells assessed as cell growth inhibition measured after 18 hrs followed by compound washout by Celltiter-Glo luminescence assay
Cytotoxicity against human KOPT-K1 cells assessed as cell growth inhibition measured after 18 hrs followed by compound washout by Celltiter-Glo luminescence assay
|
[PMID: 37197477] |
| KOPTK1 | IC50 |
2.2 μM
Compound: 25
|
Cytotoxicity against human KOPT-K1 cells assessed as cell growth inhibition measured after 18 hrs by Celltiter-Glo luminescence assay
Cytotoxicity against human KOPT-K1 cells assessed as cell growth inhibition measured after 18 hrs by Celltiter-Glo luminescence assay
|
[PMID: 37197477] |
| KOPTK1 | IC50 |
2.8 μM
Compound: 25
|
Cytotoxicity against human KOPT-K1 cells assessed as cell growth inhibition measured after 48 hrs by Celltiter-Glo luminescence assay
Cytotoxicity against human KOPT-K1 cells assessed as cell growth inhibition measured after 48 hrs by Celltiter-Glo luminescence assay
|
[PMID: 37197477] |
| RPMI 8402 | IC50 |
2.9 μM
Compound: 25
|
Cytotoxicity against human RPMI 8402 cells assessed as cell growth inhibition measured after 48 hrs by Celltiter-Glo luminescence assay
Cytotoxicity against human RPMI 8402 cells assessed as cell growth inhibition measured after 48 hrs by Celltiter-Glo luminescence assay
|
[PMID: 37197477] |
化学情報
-
CAS 番号 2902651-64-1
-
性状 Solid
-
分子量 368.82
-
分子式 C19H17ClN4O2
-
Color White to off-white
-
SMILES
O=C(CCl)NC1=CC(OC2=NC=NC(NCC3=CC=CC=C3)=C2)=CC=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
DMSO : 125 mg/mL (338.92 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 6.25 mg/mL (16.95 mM); Clear solution
This protocol yields a clear solution of ≥ 6.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (62.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
純度とドキュメンテーション
-
データシート (268 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.7113 mL | 13.5567 mL | 27.1135 mL | 67.7837 mL |
| 5 mM | 0.5423 mL | 2.7113 mL | 5.4227 mL | 13.5567 mL | |
| 10 mM | 0.2711 mL | 1.3557 mL | 2.7113 mL | 6.7784 mL | |
| 15 mM | 0.1808 mL | 0.9038 mL | 1.8076 mL | 4.5189 mL | |
| 20 mM | 0.1356 mL | 0.6778 mL | 1.3557 mL | 3.3892 mL | |
| 25 mM | 0.1085 mL | 0.5423 mL | 1.0845 mL | 2.7113 mL | |
| 30 mM | 0.0904 mL | 0.4519 mL | 0.9038 mL | 2.2595 mL | |
| 40 mM | 0.0678 mL | 0.3389 mL | 0.6778 mL | 1.6946 mL | |
| 50 mM | 0.0542 mL | 0.2711 mL | 0.5423 mL | 1.3557 mL | |
| 60 mM | 0.0452 mL | 0.2259 mL | 0.4519 mL | 1.1297 mL | |
| 80 mM | 0.0339 mL | 0.1695 mL | 0.3389 mL | 0.8473 mL | |
| 100 mM | 0.0271 mL | 0.1356 mL | 0.2711 mL | 0.6778 mL |